COO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.68

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

-0.02

EPS Last/This Y

2.75

EPS This/Next Y

0.37

Price

67.89

Target Price

79.21

Analyst Recom

2.05

Performance Q

-2.92

Upside

-61.8%

Beta

0.83

Ticker: COO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-18	COO	60.93	0.53	0.57	3972
2026-05-19	COO	61.45	0.55	4.62	4317
2026-05-20	COO	61.73	0.67	1.56	4665
2026-05-21	COO	62.84	0.74	1.72	4831
2026-05-22	COO	62.57	0.79	0.10	4993
2026-05-26	COO	62	0.76	0.36	5119
2026-05-27	COO	60.79	0.78	0.93	5111
2026-05-28	COO	61.02	0.77	0.32	5254
2026-05-29	COO	61.21	0.74	3.83	5456
2026-06-02	COO	59.46	0.74	3.05	5718
2026-06-03	COO	60.32	0.86	1.25	6165
2026-06-04	COO	62.06	0.85	0.38	6224
2026-06-05	COO	67.35	0.54	0.16	12767
2026-06-08	COO	66.79	0.62	0.17	12601
2026-06-09	COO	68.6	0.62	0.12	13015
2026-06-10	COO	67.68	0.65	0.48	12790
2026-06-11	COO	67.51	0.65	0.42	12756
2026-06-12	COO	67.89	0.65	0.04	12828
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-18	COO	60.94	14.4	93.6	4.62
2026-05-19	COO	61.44	14.4	84.4	4.62
2026-05-20	COO	61.75	14.4	82.3	4.62
2026-05-21	COO	62.81	14.4	90.7	4.62
2026-05-22	COO	62.55	14.4	76.0	4.62
2026-05-26	COO	62.01	14.4	73.5	4.62
2026-05-27	COO	60.79	14.4	66.1	4.62
2026-05-28	COO	61.01	14.4	81.3	4.62
2026-05-29	COO	61.21	14.4	81.2	4.62
2026-06-01	COO	60.17	14.2	67.9	4.62
2026-06-02	COO	59.47	14.2	71.5	4.62
2026-06-03	COO	60.33	14.1	88.6	4.62
2026-06-04	COO	62.09	14.1	98.1	4.62
2026-06-05	COO	67.36	14.1	134.4	4.62
2026-06-08	COO	66.79	8.1	73.8	4.62
2026-06-09	COO	68.65	1.8	65.6	4.63
2026-06-10	COO	67.68	1.8	45.6	4.63
2026-06-11	COO	67.52	1.8	51.2	4.63
2026-06-12	COO	67.89	1.9	55.1	4.63
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-18	COO	1.24	-3.87	2.78
2026-05-19	COO	1.24	-3.87	2.78
2026-05-20	COO	1.24	-3.87	2.78
2026-05-21	COO	1.24	-3.87	2.78
2026-05-22	COO	1.24	-3.87	2.78
2026-05-26	COO	1.24	2.35	2.78
2026-05-27	COO	1.26	2.35	2.78
2026-05-28	COO	1.26	2.35	2.64
2026-05-29	COO	1.26	2.35	2.64
2026-06-02	COO	1.26	1.74	2.64
2026-06-03	COO	1.26	1.74	2.64
2026-06-04	COO	1.26	1.74	2.64
2026-06-05	COO	1.26	1.74	2.64
2026-06-08	COO	1.26	0.69	2.64
2026-06-09	COO	1.26	0.69	2.64
2026-06-10	COO	1.26	0.69	2.68
2026-06-11	COO	1.24	0.69	2.68
2026-06-12	COO	1.24	0.69	2.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.21

Avg. EPS Est. Current Quarter

1.12

Avg. EPS Est. Next Quarter

1.19

Insider Transactions

1.24

Institutional Transactions

0.69

Beta

0.83

Average Sales Estimate Current Quarter

1098

Average Sales Estimate Next Quarter

1105

Fair Value

70.24

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

41.4

Max Drawdown 5-Year %

-48.2

Target Price

79.21

P/E

57.33

Forward P/E

13.54

PEG

1.36

P/S

3.13

P/B

1.61

P/Free Cash Flow

23.25

EPS

1.18

Average EPS Est. Cur. Y

4.63

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.57

Relative Volume

0.76

Return on Equity vs Sector %

-24.7

Return on Equity vs Industry %

-6.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

55.1

◆ COO Healthcare

$67.88

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

4/20

Pullback

8/25

Volume

6/15

Valuation

16/20

TP/AR

1/10

Options

6/10

RSI

64.2

Range 1M

88.1%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

9/30

Estimates

5/20

Inst/Vol

3/15

Options

8/10

EPS Yr

12.3%

EPS NY

8.4%

52W%

28.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +35.4% upside

Quality

9/30

Valuation

15/30

Growth

9/25

Stability

6/10

LT Trend

2/5

Upside

+35.4%

Quality

MoS

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 15000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO

Latest News

—

Caricamento notizie per COO…

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y